NASDAQ:PRAN - Prana Biotechnology Limited
$1.97
 $-0.13
-6.19%
4:00PM EDT
2019-03-25
Prana Biotechnology Limited is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. The Company's lead product candidates are PBT2 and PBT434. The Company's lead drug candidate PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. The Company also has advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing. Its other applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease (the human variant of Mad Cow disease), and a range of orphan neurodegenerative disorders. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  PRAN     avg for
industry  
  avg for
sector  
42 stocks weight:  25. 45   0. 00   0. 00  
42 stocks rank:  2. 55 K 1. 47 K 813. 28  
# analyst opinions:  1. 00   14. 60   13. 76  

quick ratio:  4. 34   5. 02   1. 92  
current ratio:  4. 37   5. 37   2. 41  

target price low:  4. 00   86. 57   112. 35  
target price avg:  4. 00   113. 88   131. 59  
target price high:  4. 00   139. 18   151. 05  
1-yr high:  2. 59   117. 54   131. 86  
last close:  1. 97   98. 55   115. 48  
50-day avg:  1. 68   99. 18   115. 72  
200-day avg:  1. 84   97. 41   113. 92  
1-yr low:  1. 13   75. 41   92. 07  
volume:  163. 41 K 2. 47 M 4. 15 M
50-day avg volume:  98. 72 K 2. 85 M 4. 53 M
200-day avg volume:  116. 47 K 2. 93 M 4. 35 M

1-day return:  -6. 19 % 0. 22 % -0. 06 %
this week return:  -6. 19 % 0. 22 % -0. 06 %
12-wk return:  14. 53 % 10. 73 % 9. 15 %
52-wk return:  -3. 32 % 9. 95 % 19. 39 %

enterprise value (EV):  3. 03 M 51. 84 B 103. 78 B
market cap:  18. 36 M 45. 80 B 92. 73 B

shares outstanding:  536. 97 M 579. 54 M 1. 21 B
shares:  1. 34 M 579. 89 M 1. 18 B
shares short:  164. 99 K 9. 60 M 17. 98 M
shares short prior month:  99. 44 K 10. 48 M 11. 44 M
short ratio:  1. 50   5. 48   3. 47  

book value:  1. 32   13. 42   27. 58  
price/book:  1. 49   2. 67   -3. 06  
gross profits:  3. 10 M 8. 18 B 37. 21 B
operating margins:  0. 00 % -691. 69 % -99. 65 %
EBITDA margins:  -241. 82 % 12. 76 % 20. 68 %
profit margins:  -230. 02 % 9. 80 % 9. 36 %
gross margins:  95. 34 % 42. 57 % 53. 92 %

1-yr max volatility:  50. 00 % --- ---
1-yr mean volatility:  0. 13 % 0. 05 % 0. 08 %

1-yr EPS:  -0. 66   2. 98   3. 81  
P/E:  -2. 98   17. 33   25. 71  
PE/G:  -0. 04   -2. 22   0. 51  
growth:  68. 70 % 94. 22 % 28. 45 %
earnings high:  -0. 00   1. 15   1. 57  
earnings avg:  -0. 00   0. 90   1. 44  
earnings low:  -0. 00   0. 61   1. 32  
revenue high:  -0. 00   2. 74 B 10. 73 B
revenue avg:  -0. 00   2. 65 B 10. 55 B
revenue low:  -0. 00   2. 54 B 10. 35 B
return on assets:  -36. 48 % -1. 39 % 5. 03 %
return on equity:  -64. 36 % -7. 64 % 6. 55 %
revenue growth:  68. 70 % 56. 26 % 16. 88 %

beta (1yr vs S&P500):  0. 58   1. 25   0. 95  
sharpe (1yr):  0. 39   0. 55   1. 18  

held % insiders:  0. 00 % 6. 44 % 3. 73 %
held % institutions:  3. 61 % 79. 27 % 68. 99 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-03-25 : PRAN
.    + 0.744 =         0.744 :: INITIAL WEIGHT
.  + 221.307 =        222.05 :: inverse volume-to-price addition
.   + 36.497 =       258.547 :: spline projection addition
.    - 22.87 =       235.677 :: add/subtract for performance
.    x 8.534 =      2011.287 :: 13 weeks' performance factor
.     x 1.01 =      2031.915 :: one-year gains+dividend factor
.    x 1.437 =      2919.914 :: industry recommendation factor
.    x 0.996 =      2909.263 :: return on assets factor
.    x 0.994 =      2890.539 :: return on equity factor
.    x 2.541 =      7344.688 :: revenue growth factor
.    x 2.814 =     20668.264 :: current ratio factor
.     x 1.14 =     23561.645 :: quick ratio factor
.    x 1.291 =     30417.952 :: short ratio factor
.    x 2.015 =      61289.87 :: price-to-book factor
.    x 1.055 =     64690.976 :: 5-day avg > 200-day avg
.    x 1.155 =     74708.537 :: 5-day avg > 50-day avg
.    x 2.115 =    158012.464 :: P/E weight
.     x 2.19 =    346098.691 :: PE/G factor
.    x 1.653 =    571989.187 :: beta factor
.    x 0.393 =    224797.934 :: sharpe factor
.    x 2.139 =    480789.048 :: target low factor
.    x 1.338 =    643474.312 :: target mean factor
.    x 1.102 =    708794.303 :: target high factor
.    x 1.107 =    784855.764 :: industry 12-weeks return
.    x 0.907 =    711648.103 :: "drift" penalty 1 days ago
.    x 0.908 =    645845.703 :: "drift" penalty 2 days ago
.    x 0.856 =    552543.525 :: "drift" penalty 3 days ago
.    x 0.999 =    551735.103 :: "drift" penalty 4 days ago
.     x 0.91 =    502159.809 :: "drift" penalty 5 days ago
.    x 0.999 =    501699.225 :: overall "drift" factor
.      x 0.5 =    250849.612 :: largest single-day jump factor
.    x 0.066 =     16492.414 :: low price factor
.    x 0.999 =     16481.426 :: factor hist industry gain for week 12
.   cubeRoot =        25.449 :: reduced to standardize
.                     25.449 :: FINAL WEIGHT for NASDAQ:PRAN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org